Related Articles
BRAFV600E‑induced KRT19 expression in thyroid cancer promotes lymph node metastasis via EMT
Changes in MYCN expression in human neuroblastoma cell lines following cisplatin treatment may not be related to MYCN copy numbers
TPX2 is a prognostic marker and promotes cell proliferation in neuroblastoma
MYCN is amplified during S phase, and c‑myb is involved in controlling MYCN expression and amplification in MYCN‑amplified neuroblastoma cell lines
The dual HDAC and PI3K inhibitor, CUDC‑907, inhibits tumor growth and stem‑like properties by suppressing PTX3 in neuroblastoma